Immunovant (IMVT) Short Interest Ratio & Short Volume → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free IMVT Stock Alerts $30.87 +0.17 (+0.55%) (As of 05/20/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Immunovant Short Interest DataCurrent Short Interest8,960,000 sharesPrevious Short Interest8,510,000 sharesChange Vs. Previous Month+5.29%Dollar Volume Sold Short$245.86 millionShort Interest Ratio7.9 Days to CoverLast Record DateApril 30, 2024Outstanding Shares145,290,000 sharesFloat Size60,550,000 sharesShort Percent of Float14.80%Today's Trading Volume585,129 sharesAverage Trading Volume920,794 sharesToday's Volume Vs. Average64% Short Selling Immunovant ? Sign up to receive the latest short interest report for Immunovant and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartIMVT Short Interest Over TimeIMVT Days to Cover Over TimeIMVT Percentage of Float Shorted Over Time Ad Priority GoldThe 2024 Gold Rush: Unleashing Market PotentialWelcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights.Get your free information kit NOW, before it's too late. Immunovant Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20248,960,000 shares $245.86 million +5.3%14.8%7.9 $27.44 4/15/20248,510,000 shares $259.30 million -5.7%14.1%7.4 $30.47 3/31/20249,020,000 shares $291.44 million -3.5%14.9%7.3 $32.31 3/15/20249,350,000 shares $285.46 million +7.7%15.3%7.1 $30.53 2/29/20248,680,000 shares $307.01 million -3.7%14.3%6.1 $35.37 2/15/20249,010,000 shares $340.58 million +8.4%14.8%6 $37.80 Get the Latest News and Ratings for IMVT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Immunovant and its competitors with MarketBeat's FREE daily newsletter. 1/31/20248,310,000 shares $302.57 million +3.4%13.7%5.5 $36.41 1/15/20248,040,000 shares $340.57 million +7.8%13.3%5.1 $42.36 12/31/20237,460,000 shares $314.29 million -2.1%12.3%4.8 $42.13 12/15/20237,620,000 shares $325.68 million +10.6%12.6%3.1 $42.74 11/30/20236,890,000 shares $269.61 million -2.4%11.4%3.1 $39.13 11/15/20237,060,000 shares $241.73 million +5.5%11.6%3.3 $34.24 10/31/20236,690,000 shares $221.10 million -0.3%14.3%3 $33.05 10/15/20236,710,000 shares $251.02 million -8.0%14.3%3.2 $37.41 9/30/20237,290,000 shares $279.86 million +42.1%15.5%3.5 $38.39 9/15/20235,130,000 shares $111.89 million +4.7%9.7%4.6 $21.81 8/31/20234,900,000 shares $111.28 million +28.6%9.3%4.3 $22.71 8/15/20233,810,000 shares $78.18 million +2.7%7.3%3.4 $20.52 7/31/20233,710,000 shares $84.70 million +3.6%7.2%3.4 $22.83 7/15/20233,580,000 shares $74.25 million -2.7%6.9%3.2 $20.74 6/30/20233,680,000 shares $69.81 million +7.6%7.1%3.5 $18.97 6/15/20233,420,000 shares $72.26 million -0.3%6.6%3.2 $21.13 5/31/20233,430,000 shares $72.06 million -20.4%6.7%3.4 $21.01 5/15/20234,310,000 shares $79.35 million -4.9%8.4%4.6 $18.41 4/30/20234,530,000 shares $73.11 million -3.6%8.8%5.2 $16.14 4/15/20234,700,000 shares $67.07 million -3.5%9.2%5.5 $14.27 3/31/20234,870,000 shares $75.53 million +21.8%9.4%5.2 $15.51 3/15/20234,000,000 shares $61.64 million +16.6%7.6%3.9 $15.41 2/28/20233,430,000 shares $59.92 million +19.9%6.6%3.2 $17.47 2/15/20232,860,000 shares $51.85 million +23.3%5.5%2.6 $18.13 1/31/20232,320,000 shares $41.23 million -4.5%4.4%2 $17.77 1/15/20232,430,000 shares $45.20 million -32.5%4.7%2.1 $18.60 12/30/20223,600,000 shares $63.90 million +27.2%7.0%3.2 $17.75 12/15/20222,830,000 shares $43.04 million +8.0%5.5%2 $15.21 11/30/20222,620,000 shares $34.35 million -9.7%5.1%2.1 $13.11 11/15/20222,900,000 shares $38.54 million +7.8%5.6%2.6 $13.29 10/31/20222,690,000 shares $30.13 million -11.2%6.2%2.5 $11.20 10/15/20223,030,000 shares $27.85 million +6.3%7.0%3.2 $9.19 9/30/20222,850,000 shares $15.90 million +7.1%6.5%3.4 $5.58 9/15/20222,660,000 shares $13.51 million +56.5%6.7%7.8 $5.08Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. 8/31/20221,700,000 shares $8.76 million +9.0%4.3%5 $5.15 8/15/20221,560,000 shares $8.05 million -4.9%3.8%4.6 $5.16 7/31/20221,640,000 shares $6.76 million -9.9%4.0%5.2 $4.12 7/15/20221,820,000 shares $7.90 million +1.1%4.4%5.4 $4.34 6/30/20221,800,000 shares $7.02 million -13.0%4.4%4.9 $3.90 6/15/20222,070,000 shares $7.14 million -10.4%5.0%5 $3.45 5/31/20222,310,000 shares $9.79 million +0.9%5.6%4.5 $4.24 5/15/20222,290,000 shares $9.25 million -8.8%5.5%4.3 $4.04 4/30/20222,510,000 shares $11.57 million +3.3%6.1%4.3 $4.61 4/15/20222,430,000 shares $12.15 million +5.2%5.9%3.9 $5.00 3/31/20222,310,000 shares $12.73 million -17.5%5.6%3.3 $5.51 3/15/20222,800,000 shares $14.76 million -3.1%6.8%4.1 $5.27 2/28/20222,890,000 shares $16.13 million +8.2%7.1%4.2 $5.58 2/15/20222,670,000 shares $15.27 million +1.1%6.6%3.7 $5.72 1/31/20222,640,000 shares $18.45 million +2.7%6.5%3.7 $6.99 1/15/20222,570,000 shares $20.20 million +11.3%N/A0 $7.86 12/31/20212,310,000 shares $19.68 million -28.3%5.7%3.6 $8.52 12/15/20213,220,000 shares $25.34 million -5.6%8.0%5.4 $7.87 11/30/20213,410,000 shares $26.26 million +3.0%8.4%6.7 $7.70 11/15/20213,310,000 shares $27.08 million -10.8%8.2%6.1 $8.18 10/29/20213,710,000 shares $29.83 million +4.2%9.2%5.9 $8.04 10/15/20213,560,000 shares $31.04 million -1.9%8.8%3.6 $8.72 9/30/20213,630,000 shares $31.54 million -15.2%9.0%3.5 $8.69 9/15/20214,280,000 shares $36.51 million -5.5%10.6%4.1 $8.53 8/31/20214,530,000 shares $39.23 million -11.5%11.2%4.2 $8.66 8/13/20215,120,000 shares $40.35 million +9.6%18.5%3.4 $7.88 7/30/20214,670,000 shares $48.85 million +2.2%20.5%3.2 $10.46 7/15/20214,570,000 shares $46.11 million -19.8%11.5%4 $10.09 6/30/20215,700,000 shares $60.25 million +6.0%14.3%5.2 $10.57 6/15/20215,380,000 shares $57.89 million -2.9%13.5%4.8 $10.76 5/28/20215,540,000 shares $83.99 million -13.7%13.9%4.8 $15.16 5/14/20216,420,000 shares $93.80 million +11.7%16.2%5.9 $14.61 4/30/20215,750,000 shares $93.73 million No Change14.2%4.3 $16.30 4/15/20215,750,000 shares $91.51 million -10.9%14.2%3.7 $15.92 3/31/20216,450,000 shares $96.75 million +41.1%15.9%4.1 $15.00 3/15/20214,570,000 shares $77.64 million +20.3%11.1%2.9 $16.99 2/26/20213,800,000 shares $60.57 million +12.4%9.2%2.7 $15.94 2/12/20213,380,000 shares $79.40 million +34.7%8.2%3.3 $23.49 1/29/20212,510,000 shares $98.44 million -1.6%6.2%3.3 $39.22 1/15/20212,550,000 shares $113.50 million -7.3%6.3%6.1 $44.51 12/31/20202,750,000 shares $135.66 million +118.3%6.8%6.7 $49.33 12/15/20201,260,000 shares $61.66 million -8.7%3.1%3 $48.94 11/30/20201,380,000 shares $68.77 million -28.1%3.4%3.2 $49.83 11/15/20201,920,000 shares $97.29 million -18.3%4.8%3.7 $50.67 10/30/20202,350,000 shares $100.93 million -7.1%7.7%4.4 $42.95 10/15/20202,530,000 shares $105.70 million +6.8%6.9%5 $41.78 9/30/20202,370,000 shares $83.40 million +52.9%6.4%5 $35.19 9/15/20201,550,000 shares $59.95 million +31.4%4.5%3 $38.68 8/31/20201,180,000 shares $40.07 million +26.9%3.5%2.2 $33.96 8/14/2020929,700 shares $25.40 million -13.9%2.7%2 $27.32Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. 7/31/20201,080,000 shares $24.42 million -8.5%3.1%2.5 $22.61 7/15/20201,180,000 shares $28.54 million -11.9%3.4%2.8 $24.19 6/30/20201,340,000 shares $32.63 million +205.7%5.8%3 $24.35 6/15/2020438,300 shares $11.23 million -57.5%2.4%1.2 $25.63 5/29/20201,030,000 shares $26.43 million -24.3%5.5%3.9 $25.66 5/15/20201,360,000 shares $26.33 million -11.7%7.3%5.9 $19.36 4/30/20201,540,000 shares $28.58 million +32.8%5.6%8.2 $18.56 4/15/20201,160,000 shares $20.89 million +72.5%6.0%7 $18.01 3/31/2020672,400 shares $12.78 million -17.4%3.8%4.9 $19.01 3/13/2020813,900 shares $12.65 million +8.8%16.7%7.3 $15.54 2/28/2020747,900 shares $8.23 million +6.4%15.4%5.6 $11.01 2/14/2020703,000 shares $10.59 million +5.8%14.4%4.4 $15.06 1/31/2020664,500 shares $9.85 million +48.9%13.6%3.6 $14.83 1/15/2020446,300 shares $7.01 million +41.8%9.2%2.5 $15.70 12/31/2019314,800 shares $5.06 million No Change6.5%1.9 $16.07 IMVT Short Interest - Frequently Asked Questions What is Immunovant's current short interest? Short interest is the volume of Immunovant shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 8,960,000 shares of IMVT short. 14.80% of Immunovant's shares are currently sold short. Learn More on Immunovant's current short interest. What is a good short interest ratio for Immunovant? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IMVT shares currently have a short interest ratio of 8.0. Learn More on Immunovant's short interest ratio. Which institutional investors are shorting Immunovant? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Immunovant: Walleye Trading LLC, PEAK6 Investments LLC, Twin Tree Management LP, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Immunovant? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 14.80% of Immunovant's floating shares are currently sold short. Is Immunovant's short interest increasing or decreasing? Immunovant saw a increase in short interest in April. As of April 30th, there was short interest totaling 8,960,000 shares, an increase of 5.3% from the previous total of 8,510,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Immunovant's float size? Immunovant currently has issued a total of 145,293,000 shares. Some of Immunovant's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Immunovant currently has a public float of 60,550,000 shares. How does Immunovant's short interest compare to its competitors? 14.80% of Immunovant's shares are currently sold short. Here is how the short interest of companies compare to Immunovant: Krystal Biotech, Inc. (9.07%), CRISPR Therapeutics AG (17.18%), Halozyme Therapeutics, Inc. (6.69%), SpringWorks Therapeutics, Inc. (13.51%), ImmunityBio, Inc. (40.08%), Iovance Biotherapeutics, Inc. (22.64%), Denali Therapeutics Inc. (8.16%), Immunocore Holdings plc (9.37%), Twist Bioscience Co. (20.49%), Revolution Medicines, Inc. (7.59%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Immunovant stock? Short selling IMVT is an investing strategy that aims to generate trading profit from Immunovant as its price is falling. IMVT shares are trading up $0.17 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Immunovant? A short squeeze for Immunovant occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IMVT, which in turn drives the price of the stock up even further. How often is Immunovant's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IMVT, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Krystal Biotech Short Interest Data CRISPR Therapeutics Short Interest Data Halozyme Therapeutics Short Interest Data SpringWorks Therapeutics Short Interest Data ImmunityBio Short Interest Data Iovance Biotherapeutics Short Interest Data Denali Therapeutics Short Interest Data Immunocore Short Interest Data Twist Bioscience Short Interest Data Revolution Medicines Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:IMVT) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 Media**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge Alerts4 Cryptos BETTER than BitcoinTrue Market InsidersThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldBill Clinton Backing Biden Replacement???The Freeport SocietyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe #1 Crypto for AIWeiss Ratings